175 related articles for article (PubMed ID: 37216009)
1. The mitochondrial genome as a modifier of autism versus cancer phenotypes in
Wei R; Yehia L; Ni Y; Eng C
HGG Adv; 2023 Jul; 4(3):100199. PubMed ID: 37216009
[TBL] [Abstract][Full Text] [Related]
2. Copy Number Variation and Clinical Outcomes in Patients With Germline PTEN Mutations.
Yehia L; Seyfi M; Niestroj LM; Padmanabhan R; Ni Y; Frazier TW; Lal D; Eng C
JAMA Netw Open; 2020 Jan; 3(1):e1920415. PubMed ID: 32003824
[TBL] [Abstract][Full Text] [Related]
3. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
Smith IN; Thacker S; Jaini R; Eng C
J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
[TBL] [Abstract][Full Text] [Related]
4. Exploring the neurological features of individuals with germline PTEN variants: A multicenter study.
Dhawan A; Baitamouni S; Liu D; Busch R; Klaas P; Frazier TW; Srivastava S; Parikh S; Hsich GE; Friedman NR; Ritter DM; Hardan AY; Martinez-Agosto JA; Sahin M; Eng C
Ann Clin Transl Neurol; 2024 May; 11(5):1301-1309. PubMed ID: 38501559
[TBL] [Abstract][Full Text] [Related]
5. Distinct metabolic profiles associated with autism spectrum disorder versus cancer in individuals with germline PTEN mutations.
Yehia L; Ni Y; Sadler T; Frazier TW; Eng C
NPJ Genom Med; 2022 Mar; 7(1):16. PubMed ID: 35241692
[TBL] [Abstract][Full Text] [Related]
6. Differential cell cycle checkpoint evasion by PTEN germline mutations associated with dichotomous phenotypes of cancer versus autism spectrum disorder.
Hitomi M; Venegas J; Kang SC; Eng C
Oncogene; 2023 Dec; 42(50):3698-3707. PubMed ID: 37907589
[TBL] [Abstract][Full Text] [Related]
7. Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer.
Smith IN; Thacker S; Seyfi M; Cheng F; Eng C
Am J Hum Genet; 2019 May; 104(5):861-878. PubMed ID: 31006514
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.
Hendricks LAJ; Hoogerbrugge N; Venselaar H; Aretz S; Spier I; Legius E; Brems H; de Putter R; Claes KBM; Evans DG; Woodward ER; Genuardi M; Brugnoletti F; van Ierland Y; Dijke K; Tham E; Tesi B; Schuurs-Hoeijmakers JHM; Branchaud M; Salvador H; Jahn A; Schnaiter S; Anastasiadou VC; Brunet J; Oliveira C; Roht L; Blatnik A; Irmejs A; ; Mensenkamp AR; Vos JR
Eur J Med Genet; 2022 Dec; 65(12):104632. PubMed ID: 36270489
[TBL] [Abstract][Full Text] [Related]
9. Distinct Alterations in Tricarboxylic Acid Cycle Metabolites Associate with Cancer and Autism Phenotypes in Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome.
Yehia L; Ni Y; Feng F; Seyfi M; Sadler T; Frazier TW; Eng C
Am J Hum Genet; 2019 Oct; 105(4):813-821. PubMed ID: 31564436
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal neurobehavioral profiles in children and young adults with PTEN hamartoma tumor syndrome and reliable methods for assessing neurobehavioral change.
Busch RM; Frazier Ii TW; Sonneborn C; Hogue O; Klaas P; Srivastava S; Hardan AY; Martinez-Agosto JA; Sahin M; Eng C
J Neurodev Disord; 2023 Jan; 15(1):3. PubMed ID: 36641436
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome.
Busa T; Milh M; Degardin N; Girard N; Sigaudy S; Longy M; Olshchwang S; Sobol H; Chabrol B; Philip N
Eur J Paediatr Neurol; 2015 Mar; 19(2):188-92. PubMed ID: 25549896
[TBL] [Abstract][Full Text] [Related]
12. Brain morphological analysis in PTEN hamartoma tumor syndrome.
Shiohama T; Levman J; Vasung L; Takahashi E
Am J Med Genet A; 2020 May; 182(5):1117-1129. PubMed ID: 32162846
[TBL] [Abstract][Full Text] [Related]
13. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
[TBL] [Abstract][Full Text] [Related]
14. Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.
Brewer T; Yehia L; Bazeley P; Eng C
Am J Hum Genet; 2022 Aug; 109(8):1520-1533. PubMed ID: 35931053
[TBL] [Abstract][Full Text] [Related]
15. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
[TBL] [Abstract][Full Text] [Related]
16. Comparative Protein Structural Network Analysis Reveals C-Terminal Tail Phosphorylation Structural Communication Fingerprint in
Smith IN; Dawson JE; Eng C
J Phys Chem B; 2023 Jan; 127(3):634-647. PubMed ID: 36626331
[TBL] [Abstract][Full Text] [Related]
17. Clinical Implications for Germline PTEN Spectrum Disorders.
Ngeow J; Sesock K; Eng C
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
[TBL] [Abstract][Full Text] [Related]
18. PTEN Hamartoma tumor syndrome in childhood: A review of the clinical literature.
Macken WL; Tischkowitz M; Lachlan KL
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):591-610. PubMed ID: 31609537
[TBL] [Abstract][Full Text] [Related]
19. Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes.
Spinelli L; Black FM; Berg JN; Eickholt BJ; Leslie NR
J Med Genet; 2015 Feb; 52(2):128-34. PubMed ID: 25527629
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.
Rodríguez-Escudero I; Oliver MD; Andrés-Pons A; Molina M; Cid VJ; Pulido R
Hum Mol Genet; 2011 Nov; 20(21):4132-42. PubMed ID: 21828076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
